The five-PCG signature has the following two advantages in prognosis prediction: First, it is an independent factor and does not depend on known prognostic factors such as IDH mutation and tumor grade II/III; second, it has excellent prediction performance for its AUC value was higher than IDH mutation and tumor grade. The gene discussed is IDH1; the disease is neoplasm.